Yes, diabetes can cause a plethora of eye issues; some of them can make you go blind. The diabetic eye diseases include ...

Diabetes progression indicators, including chronic kidney disease and prolonged diabetes duration, were associated with greater kidney cancer risk.

Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to ...

The Belgian Diabetes Registry (BDR) coordinated a European multicenter Phase II randomized, placebo-controlled clinical trial where 80 patients with recent-onset Type 1 diabetes were randomly ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

Dapagliflozin plus methylcobalamin improved nerve function and glucose control in diabetic neuropathy.

The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 Diabetes toward cGMP manufacturing and first-in-human clinical trials Strengthening the ...